Gene Symbol | AKR7A2 |
---|---|
Entrez Gene | 8574 |
Alt Symbol | AFAR, AFAR1, AFB1-AR1, AKR7 |
Species | Human |
Gene Type | protein-coding |
Description | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
Other Description | AFB1 aldehyde reductase 1|AFB1-AR 1|HEL-S-166mP|SSA reductase|aflatoxin B1 aldehyde reductase member 2|aflatoxin beta1 aldehyde reductase|aldoketoreductase 7|epididymis secretory sperm binding protein Li 166mP|succinic semialdehyde reductase |
Swissprots | O75749 Q5TG63 O43488 |
Accessions | EAW94881 O43488 AA037839 AF026947 AAC52104 AK225267 AK303131 BAG64236 AK310609 BC004111 AAH04111 BC007352 AAH07352 BC010852 AAH10852 BC011586 AAH11586 BC012171 AAH12171 BC013996 AAH13996 BG385885 BK000395 DAA00088 BM551906 BT007347 AAP36011 BU944847 DQ891003 ABM81929 DQ894182 ABM85108 EU794591 ACJ13645 Y16675 CAA76347 XR_946785 NM_003689 NP_003680 |
Function | Catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. May have an important role in producing the neuromodulator gamma-hydroxybutyrate (GHB). Has broad substrate specificity. Has NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2- nitrobenzaldehyde and pyridine-2-aldehyde (in vitro). Can reduce 1,2-naphthoquinone and 9,10-phenanthrenequinone (in vitro). Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen. {ECO:0000269|PubMed:17591773, ECO:0000269|PubMed:9576847}. |
Subcellular Location | Golgi apparatus {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:9576847}. |
Tissue Specificity | Detected in brain, liver, small intestine and testis, and at lower levels in heart, prostate, skeletal muscle and spleen. Detected in kidney proximal and distal tubules, endothelial cells lining the Bowman's capsules and some cysts. Detected at low levels in lung and pancreas (at protein level). Widely expressed. {ECO:0000269|PubMed:10510318, ECO:0000269|PubMed:9576847}. |
Top Pathways | Metabolism of xenobiotics by cytochrome P450 |
Active human AKR7A2 full length protein - ab168001 from Abcam
|
||||||||||
Human AKR7A2 full length protein - ab93634 from Abcam
|
||||||||||
AKR7A2 / AFAR Antibody Blocking Peptide - LS-E23692 from LifeSpan Bioscience
|
||||||||||
AKR7A2 / AFAR Antibody Blocking Peptide - LS-E8747 from LifeSpan Bioscience
|
||||||||||
AKR7A2 Recombinant Protein - H00008574-P02 from Novus Biologicals
|
||||||||||
AKR7A2 Recombinant Protein - H00008574-P01 from Novus Biologicals
|
||||||||||
Recombinant Human AKR7A2 Protein - P3498 from Novus Biologicals
|
||||||||||
AKR7A2-Antibody-N-term-Blocking-Peptide - BP7186a from Abgent, a WuXi AppTec company
|
||||||||||
AKR7A2 Protein (OPPA01826) - OPPA01826 from Aviva Systems Biology
|
||||||||||
Human Aldo-Keto Reductase Family Member A2 protein - orb90024 from Biorbyt
|
||||||||||
AKR7A2 protein (His tag) - 80R-1255 from Fitzgerald
|
||||||||||
AKR7A2 (1-359, His-tag) - AR09377PU-L from Acris Antibodies
|
||||||||||
AKR7A2 (1-359, His-tag) - AR09377PU-N from Acris Antibodies
|
||||||||||
AKR7A2 - H00008574-P01-10 from Acris Antibodies
|
||||||||||
AKR7A2 - H00008574-P01-25 from Acris Antibodies
|
||||||||||
AKR7A2 - H00008574-P02 from Acris Antibodies
|
||||||||||
AKR7A2 - H00008574-P02-10 from Acris Antibodies
|
||||||||||
AKR7A2 - H00008574-P02-25 from Acris Antibodies
|
||||||||||
AKR7A2 - P3498 from Acris Antibodies
|
||||||||||
AKR7A2, 1-359aa, Human, His tag, E. coli - 01-1780-A2 from ARP American Research Products
|
||||||||||
AKR7A2 fusion protein - Ag1049 from Proteintech Group
|
||||||||||
AKR7A2 Human - ENPS-492 from NeoScientific
|
||||||||||
Recombinant Human AKR7A2 - BP000863-ENZ-485 from Syd Labs
|
||||||||||
AKR7A2, 1-359aa, Recombinant Protein - GWB-P1560M from Genway Biotech
|
||||||||||
Recombinant Human AKR7A2, His-tagged - AKR7A2-26147TH from Creative Biomart
|